Dr Faye N Hant, DO | |
96 Jonathan Lucas St, Suite 912 Csb, Charleston, SC 29425-8900 | |
(843) 792-3484 | |
(843) 792-7121 |
Full Name | Dr Faye N Hant |
---|---|
Gender | Female |
Speciality | Rheumatology |
Experience | 23 Years |
Location | 96 Jonathan Lucas St, Charleston, South Carolina |
Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1043392392 | NPI | - | NPPES |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207RR0500X | Internal Medicine - Rheumatology | 0861 (South Carolina) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Musc Medical Center | Charleston, SC | Hospital |
Group Practice Name | Group PECOS PAC ID | No. of Members |
---|---|---|
University Medical Associates Of The Medical University Of South Carol | 6305758574 | 1297 |
News Archive
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced the completion of patient enrollment for its phase 3 clinical trial to study L-glutamine as a treatment for sickle cell disease.
One of the most challenging tasks of physicians has been differentiating between persistent COVID-19 and SARS-CoV-2 reinfection. Recently, a team of researchers analyzed SARS-CoV-2 sequences from the publicly available reports on reinfection and persistence. They further characterized the markers of reinfecting sequences and studied the mutation rate in newly evolved persistent variants.
Today's headlines include reports about the readiness of the health law's insurance online marketplaces for the Oct. 1 enrollment kick-off date.
› Verified 1 days ago
Entity Name | University Medical Associates Of The Medical University Of South Carol |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1043241110 PECOS PAC ID: 6305758574 Enrollment ID: O20031105000291 |
News Archive
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced the completion of patient enrollment for its phase 3 clinical trial to study L-glutamine as a treatment for sickle cell disease.
One of the most challenging tasks of physicians has been differentiating between persistent COVID-19 and SARS-CoV-2 reinfection. Recently, a team of researchers analyzed SARS-CoV-2 sequences from the publicly available reports on reinfection and persistence. They further characterized the markers of reinfecting sequences and studied the mutation rate in newly evolved persistent variants.
Today's headlines include reports about the readiness of the health law's insurance online marketplaces for the Oct. 1 enrollment kick-off date.
› Verified 1 days ago
Mailing Address | Practice Location Address |
---|---|
Dr Faye N Hant, DO 4115 E Amy Ln, Johns Island, SC 29455-8178 Ph: (843) 557-0701 | Dr Faye N Hant, DO 96 Jonathan Lucas St, Suite 912 Csb, Charleston, SC 29425-8900 Ph: (843) 792-3484 |
News Archive
A new theory that explains why the language of our genes is more complex than it needs to be also suggests that the primordial soup where life began on earth was hot and not cold, as many scientists believe.
Emmaus Medical, Inc., a specialty pharmaceutical and regenerative medicine company, today announced the completion of patient enrollment for its phase 3 clinical trial to study L-glutamine as a treatment for sickle cell disease.
One of the most challenging tasks of physicians has been differentiating between persistent COVID-19 and SARS-CoV-2 reinfection. Recently, a team of researchers analyzed SARS-CoV-2 sequences from the publicly available reports on reinfection and persistence. They further characterized the markers of reinfecting sequences and studied the mutation rate in newly evolved persistent variants.
Today's headlines include reports about the readiness of the health law's insurance online marketplaces for the Oct. 1 enrollment kick-off date.
› Verified 1 days ago
Dr. Jeffrey Peter Yourshaw, M.D. Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 169 Ashley Ave, Room 202 Main Hospital Msc 333, Charleston, SC 29425 Phone: 843-876-4807 Fax: 843-876-4809 | |
Jennifer Lee Martin, D.O. Rheumatology Medicare: Not Enrolled in Medicare Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Nikko Rowe Asuncion Tabliago, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 843-792-2575 | |
Moses K Asempah, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 169 Ashley Avenue, Room 202 Main Hospital Msc333, Charleston, SC 29425 Phone: 717-491-3745 | |
Paige Nicole Laverick, PA-C Rheumatology Medicare: Medicare Enrolled Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Amit Agrawal, MD Rheumatology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 | |
Yevgeniy Gelfand, MD Rheumatology Medicare: Medicare Enrolled Practice Location: 67 President St, Charleston, SC 29425 Phone: 843-792-0111 |